In industry parlance, Cargo had become a “zombie,” an unprofitable company with little hope for growth, but enough money to ...

On this week's episode of "The Readout LOUD": a closer look at the NIH’s grant-cutting legal playbook, FDA transparency ...

CARGO Therapeutics to be acquired by Concentra Biosciences with shareholders receiving $4.379 per share and future asset sale ...

Family offices made 60 direct investments in companies, ending three straight months of declining deal activity.

The companies Insmed, Cidara Therapeutics, and Cogent Biosciences bagged the biggest biotech funding rounds overall in June ...

Ocugen co-founder and CEO Shankar Musunuri, Ph.D. explains what biotech leaders can learn from the Philadelphia Eagles, an agile team with a championship mindset.

Fintel reports that on July 11, 2025, Raymond James initiated coverage of Vir Biotechnology (NasdaqGS:VIR) with a Outperform recommendation. Analyst Price Forecast Suggests 232.11% Upside As of June ...

Former Senior Trump Health Official Urges Focus on Innovative "Upstream" Approaches that Disrupt Current Paradigm of Costly Chronic Care ...

Vienna’s biotech sector soared to €22.7B in 2023, fueling innovation, research, and jobs. Discover what is driving the boom.

According to new data, the global plant biotechnology market is projected to grow from $51.7 billion in 2025 to nearly $77 ...